Table 3.
Product | Dosage | V1 | V2 | V3 | ΔV2–V1 | ΔV3–V2 | ΔV3–V1 |
---|---|---|---|---|---|---|---|
NAC (n=20) | Total GSH | 800.24±94.87 | 825.53±127.62 | 821.0±124.88 | 30.35±74.73 | 4.31±47.6 | 27.0±77.75 |
GSSG | 17.32±5.24 | 17.87±4.38 | 15.60±4.83 | 0.55±4.03 | −1.66±2.91 | −7.33±11.0 | |
GSH | 765.59±91.94 | 789.79±122.83 | 789.80±119.40 | 24.21±63.64 | 11.14±45.80 | 30.95±71.84 | |
PO (n=20) | Total GSH | 823.29±90.51 | 782.69±96.89 | 789.88±133.55 | -37.44±72.41 | 3.19±103.63 | -33.41±84.01 |
GSSG | 16.32±3,48 | 16.08±4.10 | 18.60±5.29 | −0.06±3.34 | 2.33±6.32 | 2.28±4.62 | |
GSH | 790.66±87.99 | 750.54±96.90 | 752.68±129.53 | −37.58±67,78 | -1.46±99.74 | −37.98±80.58 | |
SL (n=20) | Total GSH | 811.12±99.77 | 846.0±127.88 | 838.76±97.69 | 34.88±61.52 | −7.24±50.57 | 27.65±57.71 |
GSSG | 17.61±4.03 | 16.54±4.70 | 15.62±3.62 | −1.07±4.17 | −0.92±4.38 | −2.01±4.26 | |
GSH | 774.71±99.45 | 812.92±122.90 | 807.53±96.15 | 38.73±57.96 | −5.39±48.25 | 32.41±57.54 |